Physical Therapists in Fort Leavenworth, KS Accepting Medicare
8 Physical Therapists found. Showing 1 - 8
 Mrs. Lisa Jean Hover, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 550 Pope Ave, Munson Army Health Center (attn: Mxcn-cod, Ms. Cotton), Fort Leavenworth, KS 66027 Phone: 913-684-6562 Fax: 913-684-6208 |
Mrs. Elesa Ann Johnson, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 550 Pope Ave, Munson Army Health Center (attn: Mcxn-cod, Ms. Cotton), Fort Leavenworth, KS 66027 Phone: 913-684-6562 Fax: 913-684-6208 |
 Kyle Edward Parks, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 550 Pope Ave, Fort Leavenworth, KS 66027 Phone: 913-684-6338 |
Jennah Renae Bulen, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 550 Pope Ave, Fort Leavenworth, KS 66027 Phone: 913-684-6180 |
Jordan Spradlin, DPT Physical Therapist - Orthopedic Medicare: Medicare Enrolled Practice Location: 550 Pope Ave, Fort Leavenworth, KS 66027 Phone: 913-684-6338 |
Trent Mcpherson, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 550 Pope Ave, Fort Leavenworth, KS 66027 Phone: 913-684-6234 |
Gerald Ertz, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 550 Pope Ave, Fort Leavenworth, KS 66027 Phone: 913-684-6338 |
Jennifer Klein Brewster, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 550 Pope Ave, Fort Leavenworth, KS 66027 Phone: 913-684-6250 |
News Archive
USAID introduces 'first-ever' guidance on building resiliency
On Monday, USAID Administrator Rajiv Shah "announced the launch of the agency's first-ever policy and program guidance on Building Resilience to Recurrent Crisis during an event in Washington, D.C.," according to an USAID press release.
GFT505 demonstrates dose-dependent efficacy on primary endpoint in phase 2 NASH trial
GENFIT, today announces topline results of the phase 2 GOLDEN-505 trial in NASH. Due to the unexpected rate of resolution of NASH in patients randomized to placebo who had early NASH (NAS of 3, placebo response rate>57%), along with the high number of sites for a limited sample size, the study as initially designed did not enable the trial to meet directly the primary endpoint.
UAB researchers launch first drug study to prevent onset of epilepsy in children with TSC
Researchers at the University of Alabama at Birmingham have launched the first drug study aimed at preventing or delaying the onset of epilepsy in children with a genetic condition known as tuberous sclerosis complex.
Experimental flu vaccine triggers immune response, protects against flu
Vaccine production hinges on the availability of hundreds of millions of eggs - and even with the vaccine, flu still claims somewhere around 36,000 lives in the United States during a typical year.
High alert as bird flu sweeps relentlessly across the globe
The spread of the deadly H5N1 strain of bird flu continues relentlessly across the world with the confirmation that dead swans found in Hungary and Croatia this week also succumbed to the virus.
› Verified 6 days ago
Physical Therapists
Optometrists
Chiropractors
Occupational Therapists